Growth Hormone and IGF Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.0 | Q4 | 24.5% | 0.633 | Q3 | 69.4% |
| 2024 | 1.6 | Q4 | 18.7% | 0.551 | Q3 | 65.5% |
| 2023 | 1.6 | Q4 | 24.6% | 0.448 | Q3 | 61.3% |
| 2022 | 1.4 | Q4 | 19.0% | 0.437 | Q3 | 62.0% |
| 2021 | 2.1 | Q4 | 33.6% | 0.464 | Q3 | 64.8% |
| 2020 | — | — | 0.657 | Q3 | 74.4% | |
| 2019 | — | — | 0.624 | Q3 | 73.8% | |
| 2018 | — | — | 0.796 | Q2 | 78.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1532-2238
ISSN
1096-6374
region
Western Europe
coverage
1998-2026